Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$392.81 - $485.53 $7.55 Million - $9.33 Million
-19,218 Closed
0 $0
Q1 2024

Aug 01, 2024

BUY
$407.69 - $446.08 $3.01 Million - $3.3 Million
7,394 Added 62.53%
19,218 $8.03 Billion
Q4 2023

Aug 01, 2024

BUY
$343.0 - $410.68 $4.06 Million - $4.86 Million
11,824 New
11,824 $4.81 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Generate Investment Management LTD Portfolio

Follow Generate Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generate Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Generate Investment Management LTD with notifications on news.